Quick Answer
HERON THERAPEUTICS, INC. /DE/ reported Gross Profit of $113.56 million for fiscal year 2025.
HERON THERAPEUTICS, INC. /DE/ Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $113.56M | +7.5% |
| 2024 | $105.64M | +70.6% |
| 2023 | $61.94M | +17.3% |
| 2022 | $52.80M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.30M | +12.6% | -3.8% |
| June 30, 2025 | $27.34M | +7.2% | -10.2% |
| March 31, 2025 | $30.45M | +16.1% | +30.4% |
| September 30, 2024 | $23.35M | +76.6% | -8.4% |
| June 30, 2024 | $25.51M | +119.8% | -2.7% |
| March 31, 2024 | $26.23M | +105.5% | +98.3% |
| September 30, 2023 | $13.23M | +11.7% | +14.0% |
| June 30, 2023 | $11.60M | — | -9.1% |
- HERON THERAPEUTICS, INC. /DE/ showed an increase of +7.5% in Gross Profit compared to the prior fiscal year.
- Over the 2022–2025 period, HERON THERAPEUTICS, INC. /DE/’s gross profit has grown by 115.1% (from $52.80 million to $113.56 million).
- The most recent figure is from HERON THERAPEUTICS, INC. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: